Background. Pancreatic cancer is a devastating disease; its lethality is related to rapid growth and tendency to invade adjacent organs and metastasize at an early stage. Objective. The aim of this study was to identify miRNAs and their gene targets involved in the invasive phenotype in pancreatic cancer to better understand the biological behaviour and the rapid progression of this disease. Methods. miRNA profiling was performed in isogenic matched high invasive and low-invasive subclones derived from the MiaPaCa-2 cell line and validated in a panel of pancreatic cancer cell lines, tumour, and normal pancreas. Online miRNA target prediction algorithms and gene expression arrays were used to predict the target genes of the differentially ex...
In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic duct...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and hi...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...
Pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) is one of the most lethal tumour types wo...
Background/Aims: Co-stimulating molecule B7-H4 regulates T cell-mediated immune responses, participa...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Background and Aim: Altered expression of microRNAs (miRNAs) hallmarks many cancer types. The study ...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Cancer research has generated valuable body of knowledge about the mutations that play significant r...
<div><p>In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancrea...
In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic duct...
Background: Pancreatic ductal adenocarcinoma (PDAC), the most prevalent neoplastic lethal pancreatic...
CONTEXT: While global microRNA (miRNA) expression patterns of many embryologic, physiologic, and onc...
Pancreatic cancer is a fatal cancer which is expected to exceed breast cancer as the third foremost ...
In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic duct...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and hi...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...
Pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) is one of the most lethal tumour types wo...
Background/Aims: Co-stimulating molecule B7-H4 regulates T cell-mediated immune responses, participa...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Background and Aim: Altered expression of microRNAs (miRNAs) hallmarks many cancer types. The study ...
A severe lack of early diagnosis coupled with resistance to most available therapeutic options rende...
Cancer research has generated valuable body of knowledge about the mutations that play significant r...
<div><p>In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancrea...
In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic duct...
Background: Pancreatic ductal adenocarcinoma (PDAC), the most prevalent neoplastic lethal pancreatic...
CONTEXT: While global microRNA (miRNA) expression patterns of many embryologic, physiologic, and onc...
Pancreatic cancer is a fatal cancer which is expected to exceed breast cancer as the third foremost ...
In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic duct...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and hi...
Pancreatic tumours are usually very aggressive cancer with a poor prognosis. A limitation of pancrea...